Sbi Securities Co., Ltd. Gossamer Bio, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,111 shares of GOSS stock, worth $2,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,111
Previous 9,117
87.81%
Holding current value
$2,177
Previous $8.25 Million
85.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
125Shares Held
161MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$36 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$35.5 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$19.8 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.8 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA6.36MShares$12.5 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $184M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...